Angelalign Technology (HKSE:06699) Risk Assessment

View and export this data going back to 2021. Start your Free Trial

What is Angelalign Technology Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Angelalign Technology is: Low Risk: Strong fundamentals, worth long-term holding.

Competitive Comparison of Angelalign Technology's Risk Assessment

For the Medical Instruments & Supplies subindustry, Angelalign Technology's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Angelalign Technology's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Angelalign Technology's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Angelalign Technology's Risk Assessment falls into.

Angelalign Technology (HKSE:06699) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Angelalign Technology Risk Assessment Related Terms

Thank you for viewing the detailed overview of Angelalign Technology's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Angelalign Technology (HKSE:06699) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Angelalign Technology Inc (HKSE:06699) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

AGLFF:USA

Address

No. 500 Zhengli Road, 6th Floor - 7th Floor, Building No. 7, KIC Business Center, Yangpu District, Shanghai, CHN

Website

https://www.angelalign.com

Angelalign Technology Inc is an investment holding company. It is principally engaged in clear aligner treatment solutions including treatment planning services, manufacturing, and marketing of clear aligners. The company provides dental professionals with self-developed digital orthodontics solutions. The company's Angelalign clear aligner system facilitates dental professionals throughout the entire clear aligner treatment process, including digitally-assisted case assessment support and treatment planning services, provide dental professionals with digitally-assisted case assessment support and treatment planning services, and helps dental professionals design, review and modify treatment plans.

Executives

Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Morgan Stanley	2201 Interest of corporation controlled by you
Carecapital Ea, Inc	2201 Interest of corporation controlled by you
Carecapital Management Group Llc	2201 Interest of corporation controlled by you
Carecapital Moonstone Holdings Limited	2201 Interest of corporation controlled by you
Carecapital Dental Holdings Limited	2201 Interest of corporation controlled by you
Feng Dai	2201 Interest of corporation controlled by you
Shore Lead Limited	2201 Interest of corporation controlled by you
Sky Honour Enterprises Limited	2101 Beneficial owner
Li Huamin	2307 Founder of a discretionary trust who can infl
Carecapital Orthotech Limited	2101 Beneficial owner
Chen Kai	2201 Interest of corporation controlled by you
Jovial Day Global Limited	2201 Interest of corporation controlled by you
Vast Luck Global Limited	2101 Beneficial owner
Xing Zheng Quan Qiu Ji Jin Guan Li You Xian Gong Si	2102 Investment manager

Angelalign Technology (HKSE:06699) Headlines

No Headlines